Salvage therapy for hepatocellular carcinoma with thalidomide

Table 1 Description of cases

Age (yr)
Median	58 ± 14.1
Range	21-86
Sex
Male	81
Female	18
Modality of diagnosis
Cytological/histological	33
Imaging + AFP > 400 ng/mL	30
Imaging + AFP < 400 ng/mL or unknown	36
Cirrhosis
Absent	5
Present	80
Chronic parenchymalds’	14
Causes of liver disease
Hepatitis B	58
Hepatitis C	22
Hepatitis B + C	5
Non B and Non C	6
Alcoholic	1
Child-Pugh stage (unknown = 2)
A	43
B	33
C	21
AFP (ng/mL) (unknown = 10)
10 <	17
11-400	33
400	39
Portal vein thrombosis (unknown = 3)
No	46
Yes	50
Pre ThalidomideTreatment (unknown = 7)
No	30
Yes	72
Surgery	11
PEI	16
TACE	49
Radiation	6
Chemotherpay	3